Home > Drug Search >
  • company_query: Belrose Pharma
  •   > 
Drug Filter
Category:
chemistry (35) biology (38)
Status:
Approved (1) Phase Ⅲ (8) Phase Ⅱ (34) Phase Ⅰ (29) IND Filing (1)
Clinical Stage:
Pending (6) Active (51) Discontinued (15)
Bio-Type:
Vaccine (6) Recombinant enzyme (1) Bispecific antibody (1) Other recombinant protein (1) Whole antibody (27) ADC (1)
Indication:
Acute coronary syndrome (ACS) (1) Acute lymphoblastic leukaemia (ALL) (1) Alzheimer's disease (AD) (3) Asthma (1) Atopic dermatitis (1) Bladder cancer (1) Brain ischemia (1) Breast cancer (6) Candidiasis (1) Rectal cancer (1) Chronic lymphocytic leukemia (CLL) (1) Chronic obstructive pulmonary disease (COPD) (1) Choroiditis (1) Thrombotic microangiopathy (1) Delayed graft function (1) Cystic fibrosis (CF) (1) Diabetic neuropathic pain (DNP) (1) Dry age related macular degeneration (AMD) (1) Erectile dysfunction (ED) (1) Eye disorders (1) Gastric cancer (5) Gaucher's disease (GD) (1) Glioblastoma multiforme (1) Wet age-related macular degeneration (1) HCV infection (2) Hepatocellular carcinoma (HCC) (2) Hypertension (1) Idiopathic pulmonary fibrosis (IPF) (1) Impetigo (1) Leukemia (1) Lymphoma (1) Melanoma (2) Metastatic breast cancer (1) Haematological disorders (1) Multiple myeloma (MM) (3) Multiple sclerosis (MS) (1) Non small cell lung cancer (NSCLC) (6) Non-Hodgkin’s lymphoma (NHL) (2) Osteoarthritis (OA) (1) Gynaecological cancer (1) Osteogenesis imperfecta (1) Ovarian cancer (2) Pancreatic cancer (2) Choriocarcinoma (1) Peripheral T cell lymphoma (PTCL) (1) Postoperative pain (1) Prostate cancer (6) Renal cell carcinoma (2) Rheumatoid arthritis (RA) (3) Serious Gram-negative bacteria infection (1) Sjoegren's syndrome (1) Small cell lung cancer (SCLC) (2) Soft tissue sarcoma (1) Solid tumours (15) Urinary tract infections (1) Uveitis (1) Head and neck cancer (2) Systemic bacterial infections (1) Paroxysmal Nocturnal Hemoglobinuria (PNH) (1) Neuroblastoma (1) Pain (1) Biliary cancer (1) Sickle cell disease (1) Renal carcinoma (1) Contraception (1) Hematological cancer (1) Sporadic inclusion body myositis (sIBM) (1) Glioblastoma (2) Esophagus cancer (2) Thrombosis (2) Cerebral edema diabetic ketoacidosis (1) Diabetic retinopathy (1) Hipovolemic shock (1) Mesothelioma (1) Diffuse large B cell lymphoma (1) Bacterial infection (2) Liver cancer (2) Thelassemia (1) Hypoxemia (1) hematological malignancies (2) Inflammation (3) Pemphigus vulgaris (1) Hemophilia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top